(BN) Brookfield - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA11271J1075

BN: Real Estate, Infrastructure, Energy, Ventures, Equity, Assets

Brookfield Corporation, trading under the ticker symbol BN on the NYSE, is a distinguished alternative asset manager and Real Estate Investment Trust (REIT). Established in 1997 and headquartered in Toronto, Canada, Brookfield has cultivated a robust presence with offices spanning North and South America, Europe, the Middle East, and Asia. Their expertise lies in managing a diverse array of assets, including real estate, renewable energy, infrastructure, and private equity, catering to both institutional and retail investors.

Their investment strategy is marked by a focus on sectors rich in real assets, which are often undervalued and possess significant potential for cash flow generation. This includes industrial and building materials, mining, and oil and gas. Brookfields approach emphasizes operational improvements and strategic restructuring, aiming to unlock latent value in underperforming assets. Their equity investments range from $2 million to $500 million, reflecting their agility in addressing various market opportunities.

Geographically, Brookfields reach is extensive, with concentrated efforts in North America, Brazil, Europe, and Australia. This diversification not only mitigates risk but also positions them to capitalize on emerging global trends. Their funds typically operate on a four-year investment period with a ten-year term, extendable by two years, allowing ample time for value realization. Brookfields commitment to disciplined investing and active management underscores their reputation as a reliable partner for investors seeking exposure to real assets.

Financially, Brookfields market capitalization exceeds $91 billion, with a price-to-earnings ratio of 194.77, indicating significant growth expectations. Their forward P/E of 15.77 and price-to-book ratio of 2.09 suggest a balanced approach to valuation. With a price-to-sales ratio of 0.93, they demonstrate prudent management of their revenue streams. For more insights, visit their website at https://bn.brookfield.com.

Additional Sources for BN Stock

BN Stock Overview

Market Cap in USD 84,889m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception 1983-12-30

BN Stock Ratings

Growth 5y 68.2%
Fundamental 14.1%
Dividend 18.5%
Rel. Strength 10.7
Analysts 3.78/5
Fair Price Momentum 50.09 USD
Fair Price DCF -

BN Dividends

Dividend Yield 12m 0.62%
Yield on Cost 5y 1.37%
Annual Growth 5y -3.73%
Payout Consistency 95.8%

BN Growth Ratios

Growth Correlation 3m -57.1%
Growth Correlation 12m 85.7%
Growth Correlation 5y 58.1%
CAGR 5y 17.66%
CAGR/Max DD 5y 0.43
Sharpe Ratio 12m 1.78
Alpha 19.44
Beta 1.832
Volatility 36.48%
Current Volume 2534.4k
Average Volume 20d 2987.3k
What is the price of BN stocks?
As of April 03, 2025, the stock is trading at USD 54.38 with a total of 2,534,357 shares traded.
Over the past week, the price has changed by +0.17%, over one month by -3.74%, over three months by -5.33% and over the past year by +35.32%.
Is Brookfield a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Brookfield is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 14.13 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BN as of April 2025 is 50.09. This means that BN is currently overvalued and has a potential downside of -7.89%.
Is BN a buy, sell or hold?
Brookfield has received a consensus analysts rating of 3.78. Therefor, it is recommend to hold BN.
  • Strong Buy: 2
  • Buy: 5
  • Hold: 1
  • Sell: 0
  • Strong Sell: 1
What are the forecast for BN stock price target?
According to ValueRays Forecast Model, BN Brookfield will be worth about 59.2 in April 2026. The stock is currently trading at 54.38. This means that the stock has a potential upside of +8.83%.
Issuer Forecast Upside
Wallstreet Target Price 67.9 24.8%
Analysts Target Price 67.9 24.8%
ValueRay Target Price 59.2 8.8%